116 related articles for article (PubMed ID: 1967313)
1. Synthesis and beta-adrenergic antagonist activity of stereoisomeric practolol and propranolol derivatives.
Leftheris K; Goodman M
J Med Chem; 1990 Jan; 33(1):216-23. PubMed ID: 1967313
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacologic activity of congener derivatives and model conjugates of propranolol and practolol.
Khan MM; Marr-Leisy D; Rosenkranz R; Hoffman BB; Verlander MS; Goodman M; Melmon KL
Biochem Pharmacol; 1987 Jul; 36(13):2175-82. PubMed ID: 3038116
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biologic distribution of radioiodinated beta-adrenergic antagonists.
Hanson RN; Holman BL; Davis MA
J Med Chem; 1978 Aug; 21(8):830-3. PubMed ID: 29126
[TBL] [Abstract][Full Text] [Related]
4. Bivalent ligand type beta-adrenolytics related to practolol.
Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Levy JV
Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol.
Varga E; Szöllösi J; Antal K; Kovács P; Szabó JZ
Pharmazie; 1999 May; 54(5):380-4. PubMed ID: 10368833
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol.
Harms HH; Zaagsma J; de Vente J
Life Sci; 1977 Jul; 21(1):123-8. PubMed ID: 196150
[No Abstract] [Full Text] [Related]
8. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
Bodem G; Brammell HL; Weil JV; Chidsey CA
J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
[TBL] [Abstract][Full Text] [Related]
9. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
Frisk-Holmberg M; Ostman J
J Pharmacol Exp Ther; 1977 Mar; 200(3):598-605. PubMed ID: 15099
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue.
Harms HH; Zaagsma J; Van der Wal B
Eur J Pharmacol; 1974 Jan; 25(1):87-91. PubMed ID: 4154848
[No Abstract] [Full Text] [Related]
12. Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia.
Fink GD; Paulo LG; Fisher JW
J Pharmacol Exp Ther; 1975 Apr; 193(1):176-81. PubMed ID: 237111
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of propranolol-cyclic analogues.
Castagnino E; Corsano S; Strappaghetti G; Brasili L; Gallucci P
Farmaco Sci; 1983 Sep; 38(9):679-85. PubMed ID: 6139297
[TBL] [Abstract][Full Text] [Related]
14. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
Adam KR; Pullman LG; Scholfield PC
Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
[TBL] [Abstract][Full Text] [Related]
15. Absolute configuration by asymmetric synthesis of (+)-1-(4-acetamidophenoxy)-3-(isopropylamino)-propan-z-ol (practolol).
Danilewicz JC; Kemp JE
J Med Chem; 1973 Feb; 16(2):168-9. PubMed ID: 4405110
[No Abstract] [Full Text] [Related]
16. Renal effects of propranolol, practolol and butoxamine in pentobarbital-anesthetized rats.
Shibouta Y; Nishikawa K; Kikuchi S; Shimamoto K
Eur J Pharmacol; 1979 Jan; 53(2):201-8. PubMed ID: 759198
[TBL] [Abstract][Full Text] [Related]
17. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
Large MS; Smith LH
J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
[TBL] [Abstract][Full Text] [Related]
18. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
Sugawara K; Takami N; Ozaki M
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
[TBL] [Abstract][Full Text] [Related]
19. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro.
Wenkeová J; Kuhn E; Wenke M
Eur J Pharmacol; 1976 May; 37(1):91-5. PubMed ID: 6293
[TBL] [Abstract][Full Text] [Related]
20. Effect of the rigidification of propranolol, a mixed
Franchini S; Sorbi C; Linciano P; Brasili L; Tait A
Pharmazie; 2019 Mar; 74(3):131-135. PubMed ID: 30961676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
